Conference Name:
SIT 2023

Conference Date:
March 2-3, 2023

Venue:
Crowne Plaza Shanghai Noah Square

Booth Number:
B22

Compared to traditional cell and animal models, organoids exhibit greater physiological relevance. Organoids address the issue of false positives/negatives in cell line models, preventing misjudgments of drug molecules in early development stages. They also bridge the species gap between animals and humans, providing drug responses that more closely mirror human biology. Moreover, organoids maintain high reproducibility during long-term passaging, making them suitable for high-throughput screening, significantly reducing drug development costs and timelines while improving efficiency.

At this forum, bioGenous will host a booth at B22. We warmly invite attending experts and scholars to visit and engage in discussions on the latest advancements in organoid technology in the field of small molecule drug innovation.